SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge📊Experiments🤖Agents🚦Status📑Docs
Info
ℹVision⭐Showcase📽Demo
📖

FTLD-ALS: Frontotemporal Lobar Degeneration with Motor Neuron Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-ftld-als
Related Entities
diseases-ftld-als
Metadata
slugdiseases-ftld-als
entity_typedisease
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (143)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫TDP-43 PET Ligand Development for FTD and ALS63%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h60%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
mentions🔬How do non-cell autonomous effects of autophagy dysfunction 60%
mentions🔬RNA binding protein dysregulation across ALS FTD AD60%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes60%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
mentions🧪Cryptic Exon Silencing Restoration55%
mentions🧪Glycine-Rich Domain Competitive Inhibition55%
mentions🧪Cross-Seeding Prevention Strategy55%
mentions🧫Metabolic Pathway-Targeted Therapy in ALS55%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker55%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk55%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri55%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring55%
mentions🧫Brainstem Circuit Modulation for PSP55%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT55%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study55%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio55%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design55%
mentions🧫N-of-1 Clinical Trial Design for CBS/PSP55%
mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers55%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic55%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development55%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD55%
mentions🧫PSP and CBS Biomarker Validation Study55%
mentions🧫Sleep and Respiratory Network Interaction in ALS — Experimen55%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des55%
related🔬What are the mechanisms underlying tdp-43 phase separation t54%
related🔬What are the mechanisms underlying rna binding protein dysre54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬Analyze the spectrum of microglial activation states (DAM, h54%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🔬How do non-cell autonomous effects of autophagy dysfunction 54%
related🔬RNA binding protein dysregulation across ALS FTD AD54%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes54%
related🔬RNA binding protein dysregulation across ALS FTD and AD54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr50%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model50%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
mentions🧪Smartphone-Detected Motor Variability Correction50%
mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
related🧪Smartphone-Detected Motor Variability Correction40%
related🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu40%
related🧪Cryptic Exon Silencing Restoration40%
related🧪Glycine-Rich Domain Competitive Inhibition40%
related🧪Cross-Seeding Prevention Strategy40%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub